EverSource Wealth Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16K Sell
621
-269
-30% -$6.23K ﹤0.01% 2604
2026
Q1
$18.3K Buy
890
+321
+56% +$7.24K ﹤0.01% 2556
2025
Q4
$13.5K Sell
569
-2
-0.4% -$49 ﹤0.01% 2645
2025
Q3
$14.2K Buy
571
+277
+94% +$5.96K ﹤0.01% 2604
2025
Q2
$6.76K Buy
294
+103
+54% +$2.38K ﹤0.01% 3032
2025
Q1
$4.29K Sell
191
-2,189
-92% -$50.9K ﹤0.01% 2570
2024
Q4
$46.5K Buy
2,380
+2,350
+7,833% +$46.6K ﹤0.01% 1221
2024
Q3
$546 Hold
30
﹤0.01% 2852
2024
Q2
$622 Buy
+30
New +$531 ﹤0.01% 2844
2024
Q1
Sell
-181
Closed -$4.17K 2969
2023
Q4
$4.17K Buy
+181
New +$4.05K ﹤0.01% 1927
2022
Q2
Sell
-79
Closed -$2K 1854
2022
Q1
$2K Hold
79
﹤0.01% 1564
2021
Q4
$2K Buy
+79
New +$1.97K ﹤0.01% 1604

Other funds holding PRVA

EverSource Wealth Advisors's PRVA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Privia Health (PRVA) stake by 30% in Q2 2026, selling an estimated $6.23K and leaving 621 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

EverSource Wealth Advisors first reported a position in PRVA in Q4 2021 and has held it in 12 quarters since. The position peaked at $46.5K in Q4 2024. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • EverSource Wealth Advisors held 621 shares of Privia Health worth $16K as of Q2 2026.
  • EverSource Wealth Advisors sold 269 Privia Health shares in Q2 2026, an estimated $6.23K.
  • Privia Health made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2604 holding.
  • EverSource Wealth Advisors first reported a position in Privia Health in Q4 2021 and has held it in 12 quarters since.
  • EverSource Wealth Advisors's Privia Health position peaked at $46.5K in Q4 2024.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.